BRVE insider trading — Braveheart Bio, Inc.
Over the last 90 days, insiders at Braveheart Bio, Inc. (BRVE) made 10 open-market purchases worth $124.11M and 0 open-market sales worth $0, making them net buyers by $124.11M. The largest purchase was by Chimovits Erez (Director), who bought 1,940,000 shares for $34.92M on Aug 7, 2026. 9 different insiders bought shares in this period — a cluster buy, which many investors watch closely.
Updated Oct 16, 2026.
Recent BRVE insider transactions
Every Form 4 filed by Braveheart Bio, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Ah Bio Fund Iv, L.P., Ah Equity Partners Bio Iv, L.L.C., Andreessen Marc L, Horowitz Benjamin A | 10% Owner | C · Conversion | Indirect | 9,132,420 | — | — | Form 4 |
| Aug 7, 2026 | Ah Bio Fund Iv, L.P., Ah Equity Partners Bio Iv, L.L.C., Andreessen Marc L, Horowitz Benjamin A | 10% Owner | P · Purchase | Indirect | 1,100,000 | $18.00 | $19.80M | Form 4 |
| Aug 7, 2026 | Chimovits Erez | Director | C · Conversion | Indirect | 9,132,420 | — | — | Form 4 |
| Aug 7, 2026 | Chimovits Erez | Director | P · Purchase | Indirect | 1,940,000 | $18.00 | $34.92M | Form 4 |
| Aug 7, 2026 | Orbimed Advisors Llc, Orbimed Capital Gp Ix Llc, Orbimed Genesis Gp Llc | Director | C · Conversion | Indirect | 9,132,420 | — | — | Form 4 |
| Aug 7, 2026 | Orbimed Advisors Llc, Orbimed Capital Gp Ix Llc, Orbimed Genesis Gp Llc | Director | P · Purchase | Indirect | 1,940,000 | $18.00 | $34.92M | Form 4 |
| Aug 7, 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% Owner | C · Conversion | Direct | 7,420,091 | — | — | Form 4 |
| Aug 7, 2026 | Forbion Growth Opportunities Fund Iii Cooperatief U.A., Forbion Growth Iii Management B.V., Forbion Ventures Fund Vii Cooperatief U.A., Forbion Ventures Vii Management B.V. | 10% Owner | C · Conversion | Direct | 9,132,420 | — | — | Form 4 |
| Aug 7, 2026 | Forbion Growth Opportunities Fund Iii Cooperatief U.A., Forbion Growth Iii Management B.V., Forbion Ventures Fund Vii Cooperatief U.A., Forbion Ventures Vii Management B.V. | 10% Owner | C · Conversion | Indirect | 7,990,867 | — | — | Form 4 |
| Aug 7, 2026 | Forbion Growth Opportunities Fund Iii Cooperatief U.A., Forbion Growth Iii Management B.V., Forbion Ventures Fund Vii Cooperatief U.A., Forbion Ventures Vii Management B.V. | 10% Owner | P · Purchase | Direct | 1,920,000 | $18.00 | $34.56M | Form 4 |
| Aug 7, 2026 | Forbion Growth Opportunities Fund Iii Cooperatief U.A., Forbion Growth Iii Management B.V., Forbion Ventures Fund Vii Cooperatief U.A., Forbion Ventures Vii Management B.V. | 10% Owner | P · Purchase | Indirect | 1,680,000 | $18.00 | $30.24M | Form 4 |
| Aug 7, 2026 | Rickey James Paul | Chief Financial Officer | P · Purchase | Direct | 27,777 | $18.00 | $500K | Form 4 |
| Aug 7, 2026 | Viehbacher Christopher | Director | P · Purchase | Direct | 83,333 | $18.00 | $1.50M | Form 4 |
| Aug 7, 2026 | Malek David I | Director | P · Purchase | Direct | 4,166 | $18.00 | $75K | Form 4 |
| Aug 7, 2026 | Lubner David Charles | Director | P · Purchase | Direct | 55,555 | $18.00 | $1,000K | Form 4 |
| Aug 7, 2026 | Murdoch Travis | CEO and President | P · Purchase | Direct | 83,333 | $18.00 | $1.50M | Form 4 |
| Aug 7, 2026 | Anderson Michele A. | Chief Development Officer | P · Purchase | Direct | 1,111 | $18.00 | $20K | Form 4 |
BRVE insider trading FAQ
Are insiders buying BRVE stock?
Yes. In the last 90 days, Braveheart Bio, Inc. insiders made 10 open-market purchases totaling $124.11M, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading BRVE?
Recent buyers: Ah Bio Fund Iv, L.P., Ah Equity Partners Bio Iv, L.L.C., Andreessen Marc L, Horowitz Benjamin A, Anderson Michele A., Chimovits Erez, Forbion Growth Opportunities Fund Iii Cooperatief U.A., Forbion Growth Iii Management B.V., Forbion Ventures Fund Vii Cooperatief U.A., Forbion Ventures Vii Management B.V., Lubner David Charles, Malek David I.
Where does BRVE insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.